{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-004645","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2026-09-29T14:31:04+00:00","discovered_at":"2026-09-29T14:32:00.250655+00:00","generated_at":"2026-10-12T13:45:24.757963+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Silexion Therapeutics reprices series E warrants to $0.2603, expects about $0.84M gross proceeds","bullets":["Silexion Therapeutics entered a Sept 28, 2026 inducement letter with holders of 3,216,928 series E warrants to exercise at a reduced $0.2603/share price.","The warrant exercise is expected to raise about $0.84 million gross, before H.C. Wainwright fees; closing is expected on or about Sept 29, 2026.","Silexion will issue Series F and Series G warrants for up to 6,433,856 ordinary shares at $0.2603/share; Series F lasts five years, Series G 24 months after conditions.","H.C. Wainwright & Co. is exclusive placement agent, earning a 7.0% cash fee, 1.0% management fee, and up to 225,185 placement agent warrants at $0.3254/share.","Silexion also cut the exercise price for all outstanding series E warrants covering 3,846,161 ordinary shares to $0.2603/share."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-004645","json":"https://secwatch.observer/filing/0001178913-26-004645.json","markdown":"https://secwatch.observer/filing/0001178913-26-004645.md","text":"https://secwatch.observer/filing/0001178913-26-004645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004645/0001178913-26-004645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004645/zk2636167.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:45:24.757963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}